Renal metabolism of sulindac, a novel nonsteroidal antiinflammatory agent.
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D000818:Animals; D001681:Biological Assay; D015237:Dinoprost; D015232:Dinoprostone; D066298:In Vitro Techniques; D007192:Indenes / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D009119:Muscle Contraction / Q000187:drug effects; D010477:Perfusion; D011453:Prostaglandins / Q000378:metabolism* / Q000494:pharmacology; D011458:Prostaglandins E / Q000378:metabolism; D011460:Prostaglandins F / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013467:Sulindac / Q000378:metabolism* / Q000494:pharmacology
D007192:Indenes; D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D013467:Sulindac; D015121:6-Ketoprostaglandin F1 alpha; D015237:Dinoprost; D015232:Dinoprostone